A team of researchers, led by University of Minnesota associate professor Chun Wang, have engineered a polymer “wafer” that, when placed under the tongue, can effectively deliver and preserve protein-based vaccines for diseases.
Researchers create new way to effectively deliver and preserve vaccines
A team of researchers, led by a University of Minnesota associate professor, have developed a polymer “wafer” that, when placed under the tongue, can effectively deliver and preserve protein-based vaccines for diseases. The research could open the door for vaccines that can be more easily produced and distributed to communities around the world.
The study is published in the Journal of Controlled Release, a biweekly peer-reviewed medical journal.
The membrane under the tongue—called the sublingual site—has proven to be very effective at absorbing drugs. Several drugs are delivered this way, such as nitroglycerin tablets to treat chest pain that precedes heart attacks. But large molecules, such as the proteins and nucleic acids that make up many vaccines, have historically been too big to enter the body sublingually and have to be injected with needles. These large molecules are also very fragile and must be preserved, which can be a roadblock for vaccine distribution—for example, Pfizer’s COVID-19 vaccine, which is made up of nucleic acids and requires ultra-cold storage.
With the polymer wafers, the researchers have found a solution to both of those problems—and proven that their technology works with human immunodeficiency virus (HIV) proteins. While there is not a working vaccine for HIV yet, the researchers have demonstrated a delivery method that could work once one is developed.
“People have been struggling with creating an HIV vaccine for many years, and one of the problems is how to deliver it,” said Chun Wang, corresponding author of the study and a biomedical engineering associate professor in the University of Minnesota’s College of Science and Engineering. “So the challenge becomes, can we take a large molecule like a protein, store it at room temperature, give it through the sublingual site, avoid the pain and hassle with needles, have it be absorbed, and actually generate an immune response? And it turns out that we have demonstrated it actually can work with a rather simple but elegant material platform.”
The wafer is mainly made up of two ingredients: alginate and carboxymethyl cellulose (CMC). The alginate preserves the proteins while the CMC helps the wafer stick to the sublingual membrane long enough to deliver a high concentration of the proteins. The key to making the wafer work, Wang said, was finding the right balance of the two polymers.
With further testing, the polymer wafers could also provide avenues for other vaccines—perhaps one day, for COVID-19.
“This is just a small step in this long journey,” Wang said. “If we continue this line of work, it can bring us to a point where we will have vaccines—they could be based on DNA, RNA, proteins—that can be stored without refrigeration and easily delivered under the tongue at the sublingual site. They will be quickly disseminated throughout the world because they don’t rely on certain equipment and preservation and all of that stuff. This will be particularly good for low-resource regions of the world, even in America—rural areas that are lacking certain essential facilities and infrastructure.”
Original Article: Polymer ‘wafers’ placed under the tongue could deliver vaccines of the future
More from: University of Minnesota | Mayo Clinic | University of Texas MD Anderson Cancer Center
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Vaccine delivery
- The growing promise of cancer vaccines
Following these promising results in phase II clinical trials, the vaccines are now being tested on a larger group of patients in phase III trials. The studies are expected to be complete by 2030 for ...
- TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing
Funded through the National Institute of Allergy and Infectious Diseases (NIAID), the purpose of the research collaboration between TFF Pharmaceuticals and Cleveland Clinic is to develop a ...
- Could Vaccines Of The Future Be Made With Nanoparticles?
Extremely small particles might help scientists develop vaccines that are stable at room temperature and easier to administer.
- Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
On April 28, 2024, the Telegraph reported that AstraZeneca acknowledged links between rare blood clots and the vaccine for the first time in court documents related to a November 2023 class action ...
- Birth by C-section more than doubles odds of measles vaccine failure
Birth by C-section more than doubles odds of measles vaccine failure. Researchers say it is vital that children born by caesarean section receive two doses of the measles vaccine for robust protection ...
Go deeper with Google Headlines on:
Vaccine delivery
[google_news title=”” keyword=”vaccine delivery” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Polymer wafers for drug delivery
- Surface Chemistry and 3D Printing
Surface chemistry plays a critical role in every stage of 3D printing, from ink manufacturing to deposition, and subsequent processing ...
- Nature's Blueprint: Biodegradable Materials in Engineered Drug Delivery Systems
In the field of pharmaceutical sciences, drug is delivered either by conventional mode or controlled/ targeted mode to treat the disease. In controlled drug delivery, drug concentration is maintained ...
- Scientists learn from caterpillars how to create self-assembling capsules for drug delivery
Compared to conventional drug delivery methods, the nanocapsules are not toxic and can efficiently deliver various drugs with different properties. The self-assembly process is driven by ...
- Formulation and Delivery 2024
The 2024 event will be opened by the highly acknowledged expert Thomas von Erlach, Chief Scientific Officer at Vivtex highlighting Drug Delivery Systems For Biologics. This is the event to attend to ...
- Technion scientists harness ultrasound for drug delivery and tissue implantation
The journal Small Methods presents a breakthrough in drug delivery and tissue implantation assisted by ultrasound, developed by researchers from the Technion Faculty of Biomedical Engineering.
Go deeper with Google Headlines on:
Polymer wafers for drug delivery
[google_news title=”” keyword=”polymer wafers for drug delivery” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]